New Machine Combines CT, PET Scans Into a Single Image

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

NEW YORK-A new prototype machine is producing images that combine CT and scintillation-camera-based PET scans into a single image. In a presentation at the Chemotherapy Foundation Symposium XVII, Hak Choy, MD, professor of radiation oncology, Vanderbilt University, showed images of lung cancer produced by the new device-the GE Millennium VG-code-named “Hawkeye”.

NEW YORK—A new prototype machine is producing images that combine CT and scintillation-camera-based PET scans into a single image. In a presentation at the Chemotherapy Foundation Symposium XVII, Hak Choy, MD, professor of radiation oncology, Vanderbilt University, showed images of lung cancer produced by the new device—the GE Millennium VG—code-named “Hawkeye”.

The prototype being tested at Vanderbilt has been used in more than 20 cancer patients, about half with lung cancer, Dr. Choy said. He plans to use the machine to assess response in a lung cancer trial in which stage III patients will receive induction paclitaxel (Taxol), radiation, and surgery.

“This is in very early development,” Dr. Choy said in an interview with ONI. “There are currently only two such machines in the world.” One is at Vanderbilt, where scientists have worked with the company to produce the prototype machine, and the other is in Rambam Hospital, Haifa, Israel. Dr. Choy said that the equipment has been cleared by the FDA and could become commercially available in about 6 months.

“This machine should save time in the diagnostic workup,” he said, “and should be very accurate because you’re looking at an anatomical boundary based on the CT scan and the activity of the tissue in the PET scan simultaneously.”

Dr. Choy is also enthusiastic about the equipment’s potential usefulness in radiation therapy. Currently, in lung cancer, radiation oncologists base their target areas on CT scans or chest x-rays, he said. “Whenever we see an abnormality, we treat it as a cancer, but we don’t know whether it actually is a cancer or how much of it is a cancer,” he said. “By using the Hawkeye images, we can actually pinpoint the radiation beam to the active tumor—at least in theory.”

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Video 4 - "Frontline Treatment for EGFR-Mutated Lung Cancer"
Video 3 - "NGS Testing Challenges and Considerations in NSCLC"
Related Content